MeSH term
Frequency | Condition_Probility | Animals | 31 | 0.0 |
Cell Adhesion Molecules, Neuronal/*metabolism | 3 | 13.0 |
Chick Embryo | 3 | 0.0 |
Neural Cell Adhesion Molecules/*metabolism | 2 | 10.0 |
Protein Binding/physiology | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 47 | 0.0 |
Humans | 57 | 0.0 |
Kinetics | 4 | 0.0 |
Amino Acid Sequence | 17 | 0.0 |
Base Sequence | 9 | 0.0 |
Cell Adhesion | 2 | 0.0 |
Chromosome Mapping | 5 | 0.0 |
DNA, Complementary | 2 | 0.0 |
Hamsters | 2 | 0.0 |
Molecular Sequence Data | 19 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 17 | 0.0 |
Sequence Homology, Amino Acid | 5 | 0.0 |
Tumor Cells, Cultured | 3 | 0.0 |
Binding Sites | 6 | 0.0 |
Male | 9 | 0.0 |
Cell Line | 6 | 0.0 |
LDL-Receptor Related Protein 1 | 2 | 1.0 |
Mice | 14 | 0.0 |
Recombinant Proteins/metabolism | 2 | 0.0 |
Transfection | 2 | 0.0 |
Cells, Cultured | 3 | 0.0 |
Cytokines/pharmacology | 2 | 0.0 |
Sequence Alignment | 3 | 0.0 |
Rats | 9 | 0.0 |
Antibody Affinity | 2 | 1.0 |
Chromatography, Affinity | 2 | 0.0 |
Dimerization | 2 | 0.0 |
Dose-Response Relationship, Drug | 2 | 0.0 |
Enzyme-Linked Immunosorbent Assay | 8 | 0.0 |
Protein Folding | 2 | 0.0 |
Protein Structure, Tertiary | 2 | 0.0 |
Recombinant Proteins | 2 | 0.0 |
Spleen/chemistry | 2 | 8.0 |
Calorimetry, Differential Scanning | 3 | 9.0 |
Ferritin/*immunology | 2 | 50.0 |
Protein Conformation | 6 | 0.0 |
Allosteric Regulation | 4 | 6.0 |
Antibodies, Monoclonal/*immunology | 5 | 0.0 |
Female | 15 | 0.0 |
Microsomes, Liver/metabolism | 2 | 1.0 |
Receptors, Somatotropin/metabolism | 3 | 13.0 |
COS Cells | 2 | 0.0 |
Cell Membrane/metabolism | 2 | 0.0 |
Chimeric Proteins/metabolism | 2 | 1.0 |
Linkage (Genetics) | 4 | 0.0 |
Mental Retardation/genetics | 2 | 1.0 |
Models, Genetic | 2 | 0.0 |
Mutagenesis | 2 | 0.0 |
Protein Binding | 5 | 0.0 |
Binding, Competitive | 3 | 0.0 |
Comparative Study | 6 | 0.0 |
Thermodynamics | 2 | 0.0 |
Adolescent | 2 | 0.0 |
Adult | 4 | 0.0 |
Aged | 4 | 0.0 |
Exons | 2 | 0.0 |
Genotype | 2 | 0.0 |
Middle Aged | 3 | 0.0 |
Pedigree | 3 | 0.0 |
Epitopes/immunology | 4 | 0.0 |
Mice, Inbred BALB C | 3 | 0.0 |
Alleles | 3 | 0.0 |
Polymorphism, Genetic | 5 | 0.0 |
Genes, Structural | 2 | 0.0 |
Chickens | 3 | 0.0 |
Escherichia coli Infections/microbiology | 2 | 18.0 |
Rabbits | 3 | 0.0 |
Glycosylphosphatidylinositols | 2 | 3.0 |
Structure-Activity Relationship | 2 | 0.0 |
Species Specificity | 2 | 0.0 |
Platelet Activation/*immunology | 2 | 11.0 |
Immunophenotyping | 2 | 0.0 |
Antigens, Bacterial/immunology | 2 | 1.0 |
Escherichia coli/*immunology | 3 | 8.0 |
Fimbriae, Bacterial/*immunology | 5 | 55.0 |
Models, Molecular | 2 | 0.0 |
Pregnancy | 5 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 2 | 0.0 |
Cross Reactions | 2 | 0.0 |
Molecular Weight | 5 | 0.0 |
*Chromosomes, Human, Pair 4 | 5 | 2.0 |
Hybrid Cells | 2 | 0.0 |
Muscular Dystrophies/*genetics | 2 | 2.0 |
Child | 4 | 0.0 |
Factor XI/*genetics | 2 | 100.0 |
Sequence Homology, Nucleic Acid | 2 | 0.0 |
Serotyping | 6 | 2.0 |
Electrophoresis, Polyacrylamide Gel | 3 | 0.0 |
*Antibodies, Monoclonal | 4 | 1.0 |
Antigens, Bacterial/*analysis | 3 | 17.0 |
English Abstract | 3 | 0.0 |
Escherichia coli/classification/*immunology | 2 | 100.0 |
*Fimbriae Proteins | 2 | 13.0 |
Escherichia coli Infections/*microbiology | 4 | 25.0 |
Mannose/pharmacology | 2 | 16.0 |
O Antigens | 3 | 30.0 |
Urinary Tract Infections/*microbiology | 4 | 36.0 |
Nucleic Acid Hybridization | 2 | 0.0 |
Pyelonephritis/microbiology | 2 | 50.0 |
Microscopy, Electron | 2 | 0.0 |
*Genes, Bacterial | 2 | 2.0 |
Placenta/*enzymology | 3 | 3.0 |
Variation (Genetics) | 2 | 0.0 |
Immunoelectrophoresis, Two-Dimensional | 2 | 1.0 |
Hybridomas/immunology | 2 | 1.0 |
Phenotype | 3 | 0.0 |
